Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer
Clinical trial NCT03122496 · COMPLETED
Trial details
- NCT number
- NCT03122496
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-25
- Primary completion
- 2022-06-03
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.